Feedback / Questions
TPI 287 - CNS Pharma
https://cnspharma.com/ir/press-releases/cns-pharmaceuticals-acquires-orphan-drug-designation-for-novel-late-stage-abeotaxane-tpi-287-45371249
May 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next